Aygen, B. Et Al. 2019. Ombitasvir/ Paritaprevir/ Ritonavir + Ribavirin Combination Therapy in Hepatitis C Virus Infected Patients with Genotype 4 in Real-life Practice: A Multicentre Experience. Infectious diseases and clinical microbiology (Online) , vol.1, no.2 , 97-106.

Aygen, B., Demirtürk, N., Yıldız, O., Çelik, İ., Kamalak, D., Ersöz, G., ... Batırel, A.(2019). Ombitasvir/ Paritaprevir/ Ritonavir + Ribavirin Combination Therapy in Hepatitis C Virus Infected Patients with Genotype 4 in Real-life Practice: A Multicentre Experience. Infectious diseases and clinical microbiology (Online) , vol.1, no.2, 97-106.

Aygen, Bilgehan Et Al. "Ombitasvir/ Paritaprevir/ Ritonavir + Ribavirin Combination Therapy in Hepatitis C Virus Infected Patients with Genotype 4 in Real-life Practice: A Multicentre Experience," Infectious diseases and clinical microbiology (Online) , vol.1, no.2, 97-106, 2019

Aygen, Bilgehan Et Al. "Ombitasvir/ Paritaprevir/ Ritonavir + Ribavirin Combination Therapy in Hepatitis C Virus Infected Patients with Genotype 4 in Real-life Practice: A Multicentre Experience." Infectious diseases and clinical microbiology (Online) , vol.1, no.2, pp.97-106, 2019

Aygen, B. Et Al. (2019) . "Ombitasvir/ Paritaprevir/ Ritonavir + Ribavirin Combination Therapy in Hepatitis C Virus Infected Patients with Genotype 4 in Real-life Practice: A Multicentre Experience." Infectious diseases and clinical microbiology (Online) , vol.1, no.2, pp.97-106.

@article{article, author={Bilgehan Aygen Et Al. }, title={Ombitasvir/ Paritaprevir/ Ritonavir + Ribavirin Combination Therapy in Hepatitis C Virus Infected Patients with Genotype 4 in Real-life Practice: A Multicentre Experience}, journal={Infectious diseases and clinical microbiology (Online)}, year=2019, pages={97-106} }